CAMBRIDGE, Mass., Oct. 25 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) will hold a live webcast of a
conference call at 8:00 a.m. ET on Thursday, November 1, 2007. Senior
management will discuss the Company's third-quarter 2007 financial and
operational results and upcoming activities. A presentation to accompany
the conference call will be available on the webcast. Prior to the
conference call on Thursday, November 1, 2007, the Company will announce
its financial results for the period in a press release.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
The press release, presentation and live webcast can be accessed by
visiting the Investors section of the Company's website,
http://www.millennium.com. Following the webcast, an archived version of the call
and presentation will be available at the same address for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a
novel cancer product, and has a robust clinical development pipeline of
product candidates. The Company's research, development and
commercialization activities are focused in two therapeutic areas: oncology
and inflammation. By applying its knowledge of the human genome,
understanding of disease mechanisms and industrialized drug discovery
platform, Millennium is developing an exciting pipeline of innovative
product candidates. The Company's website is http://www.millennium.com.
Contact:
Kyle Kuvalanka
Investor Relations
(617) 761-4734
SOURCE Millennium Pharmaceuticals, Inc.
 back to top
Related links:
http://www.millennium.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http://photoarchive.ap.org PRN Photo Desk
photodesk@prnewswire.com
http://www.prnewswire.com/comp/114562.html/
CONTACT:
Kyle Kuvalanka, Investor Relations of
Millennium Pharmaceuticals, Inc., +1-617-761-4734
|
